Company Profile

Canget Biotekpharma Llc
Profile last edited on: 12/4/19      CAGE: 6REQ2      UEI: TJ1JCE59GKX3

Business Identifier: Biotech and biopharma focusing on cancer treatment
Year Founded
2012
First Award
2014
Latest Award
2018
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

Elm and Carlton Street
Buffalo, NY 14221
   (716) 845-4398
   info@canget-biotek.com
   www.canget-biotek.com
Location: Single
Congr. District: 26
County: Erie

Public Profile

Canget BioTekpharma is a biotech and biopharma company, which was spun off from Roswell Park Cancer Institute (RPCI, Buffalo, New York) and focuses on development of novel, cancer-targeting anticancer agents. The firm aims to improve patient survival time and/or survival rate through controlling cancer cell drug resistance and tumor relapse by providing low toxic and cancer-targeting anticancer agents for patients. The company's drug pipeline contains 10 varius drugs treating head, neck, colon, prostate, ovarian, and lung cancer as well as mesothelioma. The firm colloborates with insitutions such as Ocean University of China, Research Triangle Institute, Shandong University School of Pharmaceutical Sciences, and State University of New York (SUNY) at Buffalo.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Key People / Management

  John Seman -- Acting CEO

  Nathan R Wall -- CEO

  Fengzhi Li -- Chief Scientific Officer

  Xiang Ling

Company News

There are no news available.